4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-003334
Chief Legal Officer sold 573 shares at $1.76 ($1,008)
From the SEC's structured data for this filing
Trades in this filing
Miller Mary · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-21 | Sale : show line 1 in the form | −573 | $1.76 | $1,008 | 82,194 | D |
| Open-market sales · 573 sh · avg $1.76 · $1,008 | ||||||
Loading xslF345X06/form4.xml…